Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase
Launched by DUKE UNIVERSITY · Feb 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Genomic Medicine Risk Assessment Care for Everyone" (GRACE) trial is focused on improving health care for people at risk of cardiovascular diseases, cancer, liver diseases, and other conditions, especially in areas with fewer resources. The goal is to create a system that helps doctors assess genetic risks and provide better care to their patients. By involving patients, their family members, and healthcare providers, the trial aims to make genomic medicine more accessible and effective for everyone.
To participate, you need to be at least 18 years old, receiving care at one of the five participating clinics, and comfortable using the Internet in English. If you join, you will fill out a survey about your health and family history, and you may receive genetic testing based on your risk assessment results. Your healthcare provider will also be involved, receiving updates about your risk assessment. This study aims to reduce health disparities and improve health outcomes for individuals and families by tailoring the program to fit different needs and resources.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Receiving primary medical care in one of the 5 participating clinics
- • Age 18 years or older
- • Able to read and communicate in English
- • Able to provide written and verbal informed consent
- • Willing to use the Internet
- Exclusion Criteria:
- • Anyone not meeting inclusion criteria
- • Previous genetic counseling and/or previous hereditary panel testing
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Callahan, Florida, United States
Jacksonville, Florida, United States
Jacksonville, Florida, United States
Jacksonville, Florida, United States
Jacksonville, Florida, United States
Jacksonville, Florida, United States
Jacksonville, Florida, United States
Orange Park, Florida, United States
Patients applied
Trial Officials
Lori Orlando, MD
Principal Investigator
Duke University
Alexander S Parker, PhD
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported